Franklin Resources Inc. purchased a new stake in Blend Labs, Inc. (NYSE:BLND - Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 665,630 shares of the company's stock, valued at approximately $2,463,000. Franklin Resources Inc. owned 0.26% of Blend Labs at the end of the most recent quarter.
A number of other large investors have also added to or reduced their stakes in the stock. Advantage Alpha Capital Partners LP bought a new position in Blend Labs in the 3rd quarter valued at about $3,253,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new stake in shares of Blend Labs during the 3rd quarter worth approximately $676,000. SG Americas Securities LLC bought a new position in Blend Labs in the third quarter valued at approximately $660,000. Fullcircle Wealth LLC acquired a new position in Blend Labs during the third quarter valued at approximately $508,000. Finally, Charles Schwab Investment Management Inc. lifted its stake in Blend Labs by 7.9% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,643,051 shares of the company's stock worth $6,161,000 after purchasing an additional 120,152 shares during the last quarter. Institutional investors and hedge funds own 52.56% of the company's stock.
Insider Activity at Blend Labs
In related news, insider Oxana Tkach sold 18,324 shares of Blend Labs stock in a transaction on Monday, November 25th. The shares were sold at an average price of $5.18, for a total transaction of $94,918.32. Following the completion of the transaction, the insider now owns 88,677 shares of the company's stock, valued at $459,346.86. This trade represents a 17.13 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Timothy J. Mayopoulos sold 56,490 shares of the business's stock in a transaction on Friday, December 6th. The shares were sold at an average price of $5.50, for a total transaction of $310,695.00. Following the completion of the transaction, the director now owns 331,130 shares in the company, valued at approximately $1,821,215. The trade was a 14.57 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 201,782 shares of company stock worth $1,011,478 over the last three months. Company insiders own 13.21% of the company's stock.
Blend Labs Stock Down 2.5 %
NYSE BLND traded down $0.11 on Friday, hitting $4.29. The company's stock had a trading volume of 4,257,007 shares, compared to its average volume of 2,404,489. The firm has a market cap of $1.10 billion, a PE ratio of -12.62 and a beta of 1.33. The company's 50-day moving average is $4.51 and its 200 day moving average is $3.67. Blend Labs, Inc. has a 1-year low of $2.08 and a 1-year high of $5.53.
Analyst Upgrades and Downgrades
Several equities analysts have recently issued reports on BLND shares. Keefe, Bruyette & Woods lifted their price target on Blend Labs from $3.25 to $3.85 and gave the company a "market perform" rating in a research note on Thursday, November 7th. Wells Fargo & Company lifted their target price on Blend Labs from $4.50 to $6.50 and gave the company an "overweight" rating in a research report on Thursday, December 5th. UBS Group raised their price target on shares of Blend Labs from $3.00 to $4.00 and gave the company a "neutral" rating in a research note on Wednesday, October 23rd. Canaccord Genuity Group reaffirmed a "buy" rating and set a $5.75 price target on shares of Blend Labs in a report on Friday, December 20th. Finally, The Goldman Sachs Group increased their price objective on shares of Blend Labs from $3.40 to $3.90 and gave the company a "buy" rating in a research note on Thursday, November 7th. Two equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Blend Labs has a consensus rating of "Moderate Buy" and a consensus price target of $5.11.
Check Out Our Latest Report on Blend Labs
About Blend Labs
(
Free Report)
Blend Labs, Inc engages in the provision of cloud-based software platform solutions for financial services firms in the United States. It operates in two segments, Blend Platform and Title365. The company's Blend Builder Platform offers a suite of products that powers digital-first consumer journeys for mortgages, home equity loans and lines of credit, vehicle loans, personal loans, credit cards, and deposit accounts; and offers mortgage products to facilitate the homeownership journey for consumers comprising close, income verification for mortgage, homeowners' insurance, and realty.
Further Reading
Before you consider Blend Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Blend Labs wasn't on the list.
While Blend Labs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for January 2025. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.